Secondary hyperparathyroidism has been recognized for more than 50 years as a cause of bone fractures. More recently, the term chronic kidney disease-mineral and bone disorder (CKD-MBD) was coined by Kidney Disease: Improving Global Outcomes (KDIGO) because of the growing evidence that there is a complex interplay between bone, various mineral metabolism parameters, including parathyroid hormone (PTH), and cardiovascular calcifications in CKD, with an obvious impact on cardiovascular complications and survival. [...]
Jadoul, M., & Labriola, L. (2024). Fracture Risk in Patients on Hemodialysis: the Lower the Parathyroid Hormone the Better? Kidney International Reports, 9(10), 2854-2856. https://doi.org/10.1016/j.ekir.2024.08.023 (Original work published 2024)